IDEXX Laboratories Executive Vice President Erickson Sells Shares on August 12, 2025.

IDEXX Laboratories Inc. / DE [IDXX] has disclosed that Erickson Michael G, Executive Vice President, has engaged in a transaction involving the sale of 318 shares at a price of $649.99 per share on August 12, 2025. Furthermore, he has also sold 87.89 shares at a price of $649.85 per share on the same date.

IDEXX Laboratories Inc. (NASDAQ:IDXX) has disclosed that Executive Vice President Michael G. Erickson has engaged in a transaction involving the sale of 318 shares at a price of $649.99 per share on August 12, 2025. Additionally, he has sold 87.89 shares at a price of $649.85 per share on the same date. These transactions were reported in the company's SEC Form 4 filing [1].

Following these sales, Erickson directly owns 11,286 shares of IDEXX Laboratories. The total sale amount was $263,233, with a weighted average price of $649.8507. This sale comes amidst a period of strong financial performance and analyst upgrades for the company.

IDEXX Laboratories reported earnings of $3.63 per share (EPS) for the second quarter of 2025, beating analyst estimates of $3.28 by $0.35. The company also saw a 10.6% increase in revenue to $1.11 billion compared to the same period last year. This performance has led to a series of analyst upgrades, with price targets now ranging from $600 to $785, indicating strong market confidence and a consensus rating of "Moderate Buy" [2].

Institutional investors have also shown interest in IDEXX Laboratories. Vanguard Group Inc., for instance, increased its position in the company by 1.5% during the first quarter of 2025, owning 9,855,937 shares valued at $4,139,010,000 [3].

These transactions by Erickson and the positive market sentiment surrounding IDEXX Laboratories suggest a favorable outlook for the company's stock. However, investors should continue to monitor the company's performance and the broader market trends.

References:
[1] https://www.tradingview.com/news/tradingview:dd05ad172d888:0-idexx-laboratories-executive-sells-shares/
[2] https://www.tradingview.com/news/tradingview:c846fd65206a0:0-idexx-laboratories-executives-sell-over-23-million-in-company-stock/
[3] https://www.marketbeat.com/instant-alerts/insider-selling-idexx-laboratories-inc-nasdaqidxx-evp-sells-5450-shares-of-stock-2025-08-12/